Tag: patent reform

Kyle Bass has lost another one of his inter partes review petitions. (If you need reminding who Kyle Bass is, see here and here.) I'm on a panel this coming Tuesday (9/8/2015) with a couple of p...

Kyle Bass, the hedge fund manager who filed a number of inter partes review petitions against pharmaceutical companies, has struck terror into the shriveled hearts of the pharmaceutical industry. The ...

Here's a video I've done to explain why the pharmaceutical companies' campaign against inter partes review is disingenuous at best: You can read more about IPRs here. Note: There was a comment on T...

We hear the same complaints over and over every time Congress tries to improve the patent system. In fact, we’ve been hearing some of them for over 70 years. Here’s a little quiz to illustrate th...

One important feature of the pending patent reform bills is the “customer stay” provision. The idea is that a business that just buys a product, either for its own use or for resale, shouldn’t b...

[caption id="attachment_5222" align="alignleft" width="300"] The ice rink in Marshall, TX[/caption] In my last post, I told you about the Eastern District of Texas and why it’s such a popular venue...

I (and others) have written about the Eastern District of Texas. It’s a judicial district that handles more patent cases than any other district in the country. In fact, one judge, Judge Rodney Gils...

A few weeks ago, I had the opportunity to sit down with Boston University School of Law Professor Michael Meurer (pronounced MOY-er). Mike wrote a paper with fellow BU Law Professor Jim Bessen that es...